Dynamic Technology Lab Private Ltd purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 66,192 shares of the company's stock, valued at approximately $1,206,000. Dynamic Technology Lab Private Ltd owned approximately 0.06% of Privia Health Group as of its most recent SEC filing.
A number of other large investors have also recently modified their holdings of the business. Sequoia Financial Advisors LLC increased its stake in Privia Health Group by 2.3% in the third quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company's stock valued at $478,000 after acquiring an additional 583 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its holdings in shares of Privia Health Group by 8.5% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company's stock worth $134,000 after purchasing an additional 605 shares in the last quarter. Arizona State Retirement System increased its position in shares of Privia Health Group by 2.4% during the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company's stock valued at $462,000 after purchasing an additional 617 shares during the last quarter. Signaturefd LLC raised its holdings in shares of Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company's stock valued at $34,000 after buying an additional 626 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its position in Privia Health Group by 9.7% in the 2nd quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company's stock worth $151,000 after buying an additional 771 shares during the last quarter. Institutional investors own 94.48% of the company's stock.
Wall Street Analysts Forecast Growth
PRVA has been the topic of several research reports. Truist Financial lifted their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. Royal Bank of Canada reiterated an "outperform" rating and issued a $28.00 target price on shares of Privia Health Group in a research report on Wednesday, August 14th. KeyCorp initiated coverage on shares of Privia Health Group in a research report on Friday, October 11th. They set an "overweight" rating and a $23.00 price target for the company. Robert W. Baird raised their price objective on Privia Health Group from $23.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, August 26th. Finally, Barclays boosted their target price on Privia Health Group from $19.00 to $21.00 and gave the company an "equal weight" rating in a research note on Friday, November 8th. Two analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $25.07.
Check Out Our Latest Stock Analysis on PRVA
Privia Health Group Stock Performance
PRVA opened at $21.50 on Wednesday. The stock has a market capitalization of $2.58 billion, a PE ratio of 215.02, a price-to-earnings-growth ratio of 5.60 and a beta of 0.76. The stock's 50 day moving average price is $19.03 and its 200-day moving average price is $18.60. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $24.30.
Insider Activity at Privia Health Group
In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of Privia Health Group stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the sale, the chief executive officer now directly owns 247,771 shares of the company's stock, valued at approximately $4,583,763.50. The trade was a 35.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 14.20% of the stock is currently owned by company insiders.
Privia Health Group Company Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
